1,494 Shares in Danaher Co. (NYSE:DHR) Acquired by Root Financial Partners LLC

Root Financial Partners LLC acquired a new position in Danaher Co. (NYSE:DHR) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 1,494 shares of the conglomerate’s stock, valued at approximately $343,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Heck Capital Advisors LLC bought a new position in Danaher in the fourth quarter worth approximately $27,000. Decker Retirement Planning Inc. bought a new position in Danaher in the fourth quarter worth approximately $31,000. Golden State Wealth Management LLC bought a new position in Danaher in the fourth quarter worth approximately $31,000. Teachers Insurance & Annuity Association of America bought a new position in Danaher in the third quarter worth approximately $39,000. Finally, MidAtlantic Capital Management Inc. bought a new position in Danaher in the third quarter worth approximately $40,000. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $206.66 on Friday. The business has a fifty day moving average of $230.00 and a 200 day moving average of $249.96. The firm has a market capitalization of $149.26 billion, a price-to-earnings ratio of 39.14, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the company posted $2.09 earnings per share. As a group, research analysts expect that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.52%. Danaher’s payout ratio is currently 20.45%.

Wall Street Analyst Weigh In

Several analysts have issued reports on DHR shares. Robert W. Baird dropped their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Wells Fargo & Company dropped their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $277.00 target price (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.